Protagenic Therapeutics executive chair Garo H. Armen acquires 2,700 common shares for $945

Garo H. Armen, Executive Chair and Principal Officer of Protagenic Therapeutics, acquired 2,700 common shares at $0.35 per share for a total of $945. This transaction increased his direct common stock holdings to 36,899 shares.

Garo H. Armen, executive chair and principal officer, bought 2,700 Protagenic Therapeutics common shares at USD 0.35. * Direct common stock holdings increased to 36,899 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039399), on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here